Skip to main content

Table 2 Schedule of assessments for the clinical trial

From: An Integrated Care Pathway for depression in adolescents: protocol for a Type 1 Hybrid Effectiveness-implementation, Non-randomized, Cluster Controlled Trial

Domain

Outcome Measurement Instrument

Rater

Follow-up Time Point (Weeks)

0

4

12

24

36

52

Demographics

Locally-developed Demographics Form

Youth

ALL

     

Diagnosis

K-SADS-PL DSM-5

Evaluator

ALL

     

Depression Symptom Severity

CDRS-R

Evaluator

ALL

ALL

ALL

ALL

ALL

ALL

MFQ

Youth

TAUa

TAUa

TAUa

TAUa

TAUa

TAUa

Depression Diagnosis

DRS

Evaluator

ALLb

 

ALL

ALL

ALL

ALL

Overall mental health

CBCL

Caregiver

ALL

  

ALL

 

ALL

Function

CADLIS

Youth

TAUa

TAUa

TAUa

TAUa

TAUa

TAUa

Function

CADLIS

Caregiver

ALL

     

Quality of Life

YQOL-R

Youth

ALL

 

ALL

ALL

ALL

ALL

Self-Injurious Thoughts and Behaviours

Lifetime C-SSRS

Evaluator

ALL

     

Past 6-month C-SSRS

Evaluator

ALL

  

ALL

 

ALL

Lifetime SITBI-NSSI

Evaluator

ALL

     

Past 6 month SITBI-NSSI

Evaluator

ALL

  

ALL

 

ALL

Global Impression

CGI-Improvement

Clinician

   

ALL

  

PGI-Severity

Youth

TAUa

TAUa

TAUa

TAUa

TAUa

TAUa

PGI-Improvement

Youth

 

TAUa

TAUa

TAUa

TAUa

TAUa

Anxiety Symptom Severity

RCADS-15-Anx

Youth

TAUa

TAUa

TAUa

TAUa

TAUa

TAUa

Symptoms of Borderline Personality Disorder

CI-BPD

Evaluator

ALL

     

Hopelessness

BHS

Youth

ALL

     

Adolescent-Caregiver Conflict

CBQ

Youth

ALL

  

ALL

 

ALL

CBQ

Caregiver

ALL

  

ALL

 

ALL

Substance Use

AADIS grid

Youth

ALL

     

Health Service Use

Past 3 month HSSU

Evaluator

ALL

 

ALL

ALL

ALL

ALL

Shared Decision-Making

Collaborate

Youth

 

ALL

ALL

ALL

ALL

ALL

Service Satisfaction

OPOC-MHA

Youth

  

ALL

ALL

ALL

ALL

CBT Skill Use

CBTSQ

Youth

ALL

ALL

ALL

ALL

ALL

ALL

COVID restrictions

COVID-Impact

Youth

ALL

 

ALL

ALL

ALL

ALL

  1. K-SADS-PL Kiddie Schedule for Affective Disorders and Schizophrenia- Life-Time Version [58], CDRS-R Childhood Depression Rating Scale -Revised [31], MFQ Mood and Feelings Questionnaire [32], DRS Depression Rating Scale (module within KSADS [58]), CBCL Childhood Behavior Checklist [34], CADLIS-Y Childhood Anxiety and Depression Life Interference Scale - Youth report [33], YQOL-R Youth Quality of Life – Revised [59, 60], C-SSRS Columbia Suicide Severity Rating Scale [46], SITBI-NSSI Self-Injurious Thoughts and Behaviours Interview – Non-Suicidal Self-Injury subsection [61], CGI Clinical Global Impression Scale [44], Patient Global Impression Scale [44], RCADS-15-Anx Revised Children’s Anxiety and Depression Scale – 15 item anxiety subscale [43], CI-BPD Childhood Interview for Borderline Personality Disorder [62], BHS Beck Hopelessness Scale [63], CBQ Conflict Behaviour Questionnaire [64], AADIS Adolescent Alcohol and Drug Involvement Scale [65], HSSU Health System Service Utilization [55], CollaboRATE [66], OPOC-MHA Ontario Perception of Care Tool for Mental Health and Addictions [67], CBTSQ-Cognitive Behavior Therapy Skills Questionnaire [68], COVID-Impact Locally-developed COVID Questionnaire regarding impact of COVID restrictions
  2. aTo manage respondent burden in CARIBOU-2 pathway arm, these self-report research measures will only be completed by youth in Treatment as Usual arm as the youth in the pathway arm will be completing these measures as part of the measurement-based care package
  3. bEmbedded in KSADS